Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children - Test2 - elhamkhani - TriplyDB

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children

http://www.wikidata.org/entity/Q28263182

about

Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malariaedit Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial Dihydroartemisinin-piperaquine vs. artemether-lumefantrine for first-line treatment of uncomplicated malaria in African children: a cost-effectiveness analysis Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine Malaria in Uganda: challenges to control on the long road to elimination: I. Epidemiology and current control efforts.Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine Exert Inverse Selective Pressure on Plasmodium Falciparum Drug Sensitivity-Associated Haplotypes in Uganda.Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan schoolchildren.Does the Use of Dihydroartemisinin-Piperaquine in Treating Patients with Uncomplicated falciparum Malaria Reduce the Risk for Recurrent New falciparum Infection More Than Artemether-Lumefantrine?Longitudinal study on Plasmodium falciparum gametocyte carriage following artemether-lumefantrine administration in a cohort of children aged 12-47 months living in Western Kenya, a high transmission area Comparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan children Artemisinin-based combination therapies are efficacious and safe for treatment of uncomplicated malaria in HIV-infected Ugandan children Increased risk of early vomiting among infants and young children treated with dihydroartemisinin-piperaquine compared with artemether-lumefantrine for uncomplicated malaria.Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania.Artemether-lumefantrine: an option for malaria.A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos.Loss and dysfunction of Vδ2⁺ γδ T cells are associated with clinical tolerance to malaria.Malaria: an update on current chemotherapy.Efficacy of quinine, artemether-lumefantrine and dihydroartemisinin-piperaquine as rescue treatment for uncomplicated malaria in Ugandan children.Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children Detection of persistent Plasmodium spp. infections in Ugandan children after artemether-lumefantrine treatment.Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial.Treating uncomplicated malaria in children: comparing artemisinin-based combination therapies.Effect of nutritional status on response to treatment with artemisinin-based combination therapy in young Ugandan children with malaria Comparative safety of artemether-lumefantrine and other artemisinin-based combinations in children: a systematic review Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants Comparative study of the efficacy and tolerability of dihydroartemisinin-piperaquine-trimethoprim versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal.Accuracy of two malaria rapid diagnostic tests (RDTS) for initial diagnosis and treatment monitoring in a high transmission setting in Uganda Comparing the impact of artemisinin-based combination therapies on malaria transmission in sub-Saharan Africa In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia.Artemether-lumefantrine versus artemisinin-naphthoquine in Papua New Guinean children with uncomplicated malaria: a six months post-treatment follow-up study Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.Seasonality in malaria transmission: implications for case-management with long-acting artemisinin combination therapy in sub-Saharan Africa.Plasmodium vivax treatments: what are we looking for?Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum.Lack of Artemisinin Resistance in Plasmodium falciparum in Uganda Based on Parasitological and Molecular Assays The association between malnutrition and the incidence of malaria among young HIV-infected and -uninfected Ugandan children: a prospective study.Rethinking Dosing Regimen Selection of Piperaquine for Malaria Chemoprevention: A Simulation Study.

P2860

Q21032449-57F25E8D-ADC8-476E-9B73-68432BBF6EA8 Q24201077-76D9373E-A4F0-4F26-9168-66B7AF5BDCCF Q26822489-D860366F-D600-486A-A918-E515694CDABC Q28125904-41CC6431-3BA8-488C-9E1D-EDDB927E4D7F Q28477853-688EAD56-C3DA-4F69-BC77-11BA9DFA45AE Q28538065-1A4EBAFF-F8BA-48A7-AB7C-354E763AB0B8 Q28542034-A5781488-6FE7-4718-9743-29DF57E05D18 Q30226671-FE3E3831-A76A-46FA-8802-898DF855FEBC Q33629027-483CA8B6-665D-4FBA-9623-B40000D3510F Q33728165-6A6B3AB5-34A8-4A41-802A-98E89466B4DC Q33874069-2D5A67D0-CF4E-4922-B6B1-9BFBE06A604C Q33928116-CE00D1B3-92CC-4AD4-B2C4-D749724D943D Q33947834-EB12C2E0-72D9-42F6-8C20-ABC4A6071BB1 Q34137766-2F59BA78-AC3A-46E7-8A43-1805C03D6D34 Q34160147-40758B59-13AC-4B49-B14C-952B55973505 Q34227179-F153891F-CB75-4DE0-8348-9C27E42FB7B9 Q34267667-DB66EFF3-FE2E-46F3-A131-4EB6F4D6132A Q34341784-36D1D132-E70A-486C-8655-4B84CDE33D8F Q34343795-D9A77792-F04D-4E9E-B7BD-45E8B5C06D65 Q34433106-6F2BE03E-0A9B-47C3-A266-84769314FB4D Q34562333-5AF5A721-64DA-4BF2-B703-0A1BE39B922E Q34600201-FBE1D759-9866-4EF7-A3E0-B0501BB89790 Q34629332-66435B22-7DB0-4FE1-890B-53E4F187E3E9 Q34748630-3A6D6122-942B-4B27-9F60-28B1055B208B Q35004430-D1061969-09DA-45A3-AAB6-71A813081D4F Q35004867-6A64B656-22E6-4B3E-8233-8BDDBECCFDB6 Q35029488-B2C6D869-8CEA-4896-95B5-BE100DE85D7D Q35055212-88FD4DDC-9CA8-48DE-B8BC-E3C6E9CA60A3 Q35137471-E6C79907-64E8-4539-9153-F2A953499A40 Q35150280-B23718DD-865B-48B1-B76E-85BCABBBAD58 Q35150299-FD409646-3B69-44EC-82D7-D8114D7191D4 Q35186075-1FD39F3C-2158-407F-BD55-2E7C109079DA Q35218484-3BEC5EC9-69E7-4279-BCD2-A169D60517F8 Q35598379-76D51504-63E0-4130-8C71-F0D83A51B2BA Q35748391-4F081825-D012-4898-9C52-ED8F6281DE1C Q35760893-26142991-2EE6-4B06-AB81-71C9C3FFDB57 Q35834198-0200DD72-77AF-4A35-90EB-44B9F1E89CED Q35860091-81AA1CC1-2D51-4CB6-A010-55FC8E2A7ECA Q35914418-AC977779-F948-40E7-BDEF-3BFC95E70F5F Q36018444-8A84B3C9-C653-4C54-A0E6-B56A2DDB7D95

P2860

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children

http://www.wikidata.org/entity/Q28263182

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Artemether-lumefantrine versus ...... rial in young Ugandan children

@ast

Artemether-lumefantrine versus ...... rial in young Ugandan children

@en

Artemether-lumefantrine versus ...... rial in young Ugandan children

@nl

type

label

Artemether-lumefantrine versus ...... rial in young Ugandan children

@ast

Artemether-lumefantrine versus ...... rial in young Ugandan children

@en

Artemether-lumefantrine versus ...... rial in young Ugandan children

@nl

prefLabel

Artemether-lumefantrine versus ...... rial in young Ugandan children

@ast

Artemether-lumefantrine versus ...... rial in young Ugandan children

@en

Artemether-lumefantrine versus ...... rial in young Ugandan children

@nl

P1433

Q28263182-58D6ABAC-9883-4043-B6C3-B53690DEB4B2

P1476

Q28263182-FB470D6B-FCC9-426A-83F3-E52D414145C4

P2093

Q28263182-43FE99C7-EA6A-4593-92DE-5E80C0A64F35

Q28263182-60D6AD31-9B35-40E5-895D-3D80740B755A

Q28263182-72E2C318-165A-4F60-BB48-535CD1A42D54

Q28263182-8F7769D5-A5EC-4163-95A2-3085061F6374

Q28263182-F7AA5CBF-E725-4EA7-A81C-73EBAEDA5E1E

Q28263182-F9F19366-45EA-4BAF-B7EC-3112AFCDDA30

P304

Q28263182-BCF8C102-9002-47BD-B768-8A389A01A631

P31

Q28263182-3C38ED38-D50D-4D55-86A3-2B08D87230F3

P3181

Q28263182-FB594878-BF83-4E45-B74F-A8576D6F38E0

P356

Q28263182-BFE4781D-F160-4329-9513-10A1A62ACAA7

P407

Q28263182-9AB85680-83C5-42F2-B7DA-5754F75209DA

P433

Q28263182-1028EADA-B690-4828-ABC2-CDF353455141

P478

Q28263182-7D597334-613F-4594-A1DD-53158AEF917E

P50

Q28263182-0D9E1DD3-AA9F-4590-9972-D6FB5648B272

Q28263182-42963602-A177-4F3A-9C7D-B7FCF588B5C1

Q28263182-5112B594-DC80-4CC7-8A59-9692E448FF66

Q28263182-9142B2B5-CC05-469C-9C19-992CDF67B4AB

Q28263182-9DAF7AE0-B180-4A94-8869-17445FA7DE4F

Q28263182-EEC276D0-2CEC-4CD3-88CB-55106B2BF064

P577

Q28263182-2DD9FB6F-D893-4C04-AAD0-A1D589F285D2

P5875

Q28263182-A06AFAC7-9FBE-4DAA-9C66-9A9AC40C42D3

P698

Q28263182-50CCBA1C-E66C-4331-9D13-E03C7949DF6B

P921

Q28263182-2F24D4FB-CB2D-43E8-AA6F-09BEFA47659E

Q28263182-739DADBE-B0E0-4436-8637-EF0AE87DED90

Q28263182-878F9189-0744-4F0E-BFA4-D9311030D459

P3181

P356

P1433

Clinical Infectious Diseases

P1476

Artemether-lumefantrine versus ...... rial in young Ugandan children

@en

P2093

Abel Kakuru

http://www.w3.org/2001/XMLSchema#string

Humphrey Wanzira

http://www.w3.org/2001/XMLSchema#string

Jaco Homsy

http://www.w3.org/2001/XMLSchema#string

Julius Kalamya

http://www.w3.org/2001/XMLSchema#string

Neil Vora

http://www.w3.org/2001/XMLSchema#string

Taylor G Sandison

http://www.w3.org/2001/XMLSchema#string

P304

1629-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1621604

http://www.w3.org/2001/XMLSchema#string

P356

10.1086/647946

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

Bryan Greenhouse

Emmanuel Arinaitwe

Philip J Rosenthal

Jordan W Tappero

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38056317

http://www.w3.org/2001/XMLSchema#string

P698

19877969

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum